DaVita HealthCare Partners Inc. (NYSE:DVA) dropped 4.9% during mid-day trading on Friday . The stock traded as low as $62.76 and last traded at $64.32, with a volume of 3,771,037 shares traded. The stock had previously closed at $67.65.

DVA has been the subject of several recent analyst reports. JPMorgan Chase & Co. raised their target price on DaVita HealthCare Partners from $74.00 to $75.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 9th. Zacks Investment Research cut DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. TheStreet cut DaVita HealthCare Partners from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Wells Fargo & Co. reissued a “buy” rating on shares of DaVita HealthCare Partners in a research note on Saturday, June 4th. Finally, Robert W. Baird reissued a “buy” rating on shares of DaVita HealthCare Partners in a research note on Sunday, May 8th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $78.00.

The company has a 50-day moving average of $75.36 and a 200-day moving average of $73.20. The stock has a market capitalization of $13.34 billion and a price-to-earnings ratio of 37.51.

DaVita HealthCare Partners (NYSE:DVA) last posted its earnings results on Monday, August 8th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.03. During the same period in the previous year, the company posted $0.95 EPS. The company earned $3.72 billion during the quarter, compared to analysts’ expectations of $3.67 billion. DaVita HealthCare Partners’s quarterly revenue was up 8.2% compared to the same quarter last year. Equities research analysts predict that DaVita HealthCare Partners Inc. will post $3.77 EPS for the current year.

In related news, insider Jeanine Marie Jiganti sold 1,291 shares of the company’s stock in a transaction that occurred on Monday, July 11th. The stock was sold at an average price of $78.51, for a total value of $101,356.41. Following the sale, the insider now owns 5,716 shares of the company’s stock, valued at approximately $448,763.16. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Michael David Staffieri sold 20,262 shares of the company’s stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $73.09, for a total value of $1,480,949.58. Following the completion of the sale, the chief operating officer now directly owns 52,279 shares in the company, valued at approximately $3,821,072.11. The disclosure for this sale can be found here.

Other large investors recently bought and sold shares of the company. Advantus Capital Management Inc raised its stake in DaVita HealthCare Partners by 0.6% in the fourth quarter. Advantus Capital Management Inc now owns 15,975 shares of the company’s stock worth $1,114,000 after buying an additional 92 shares during the last quarter. Utah Retirement Systems raised its stake in DaVita HealthCare Partners by 0.3% in the fourth quarter. Utah Retirement Systems now owns 31,618 shares of the company’s stock worth $2,204,000 after buying an additional 100 shares during the last quarter. Bridgewater Associates LP bought a new stake in DaVita HealthCare Partners during the fourth quarter worth about $2,227,000. KBC Group NV raised its stake in DaVita HealthCare Partners by 82.7% in the fourth quarter. KBC Group NV now owns 35,965 shares of the company’s stock worth $2,507,000 after buying an additional 16,281 shares during the last quarter. Finally, Jennison Associates LLC raised its stake in DaVita HealthCare Partners by 0.5% in the fourth quarter. Jennison Associates LLC now owns 440,195 shares of the company’s stock worth $30,686,000 after buying an additional 2,084 shares during the last quarter.

DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.